BG Medicine Highlights Role of Galectin-3 Testing in Combating Hospital Readmissions at the American College of Cardiology's (ACC) 62nd Annual Scientific Session & Expo
March 06, 2013 08:30 ET
|
BG Medicine, Inc.
WALTHAM, Mass., March 6, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a diagnostics company focused on the development and commercialization of novel cardiovascular tests, today announced...
BG Medicine, Inc. to Present at Cowen and Company 33rd Annual Health Care Conference
February 27, 2013 08:30 ET
|
BG Medicine, Inc.
WALTHAM, Mass., Feb. 27, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) ), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today...
BG Medicine, Inc. Announces Publication of Two Studies Supporting Repeat Galectin-3 Testing in Heart Failure Patients
February 27, 2013 08:30 ET
|
BG Medicine, Inc.
WALTHAM, Mass., Feb. 27, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a diagnostics company focused on the development and commercialization of novel cardiovascular tests, announced today...
BG Medicine, Inc. Announces Closing of Public Offering and Exercise of Over-Allotment Option
January 30, 2013 16:09 ET
|
BG Medicine, Inc.
WALTHAM, Mass., Jan. 30, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a diagnostics company focused on the development and commercialization of novel cardiovascular tests, today announced...
BG Medicine, Inc. Prices $12.0 Million Public Offering of Common Stock
January 25, 2013 09:17 ET
|
BG Medicine, Inc.
WALTHAM, Mass., Jan. 25, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a diagnostics company focused on the development and commercialization of novel cardiovascular tests, today announced...
BG Medicine, Inc. Enters Into $12 Million Common Stock Purchase Agreement With Aspire Capital Fund, LLC
January 24, 2013 16:34 ET
|
BG Medicine, Inc.
WALTHAM, Mass., Jan. 24, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, today announced that...
BG Medicine, Inc. Announces Proposed Public Offering of Common Stock
January 24, 2013 16:34 ET
|
BG Medicine, Inc.
WALTHAM, Mass., Jan. 24, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, today announced that...
BG Medicine Announces Obtaining CE Mark and Launching of Automated BGM Galectin-3 Test
January 02, 2013 16:05 ET
|
BG Medicine, Inc.
WALTHAM, Mass., Jan. 2, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that...
BG Medicine Obtains CE Mark for CardioSCORE(TM) Test in Europe
December 11, 2012 08:30 ET
|
BG Medicine, Inc.
WALTHAM, Mass., Dec. 11, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a diagnostics company focused on the development and commercialization of novel cardiovascular tests, today announced...
BG Medicine, Inc. to Present at 24th Annual Piper Jaffray Healthcare Conference
November 20, 2012 16:58 ET
|
BG Medicine, Inc.
WALTHAM, Mass., Nov. 20, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that...